Cargando…
Successful use of Infliximab in macrophage activation syndrome with severe CNS affection
Autores principales: | Sellmer, A, Stausbøl-Grøn, B, Herlin, T |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3334004/ http://dx.doi.org/10.1186/1546-0096-6-S1-P200 |
Ejemplares similares
-
Effect of infliximab in sweet’s syndrome-pyoderma gangraenosum overlap syndrome
por: Mahler, Birgitte, et al.
Publicado: (2014) -
Generalized pustular psoriasis in infant with heterozygous mutation in the IL36RN gene successfully treated with infliximab
por: Glerup, Mia, et al.
Publicado: (2014) -
Successful treatment of refractory hughes stovin syndrome with infliximab
por: Gortani, Giulia, et al.
Publicado: (2014) -
Infliximab for severe ocular inflammation in patients with Behcet's disease
por: Sfikakis, P, et al.
Publicado: (2003) -
Cytokine active disulfide-HMGB1 increased during severe macrophage activation syndrome
por: Schierbeck, Hanna, et al.
Publicado: (2014)